Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury
- PMID: 29947256
- PMCID: PMC6158550
- DOI: 10.1177/0963689718780309
Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury
Abstract
The use of mesenchymal stromal cell (MSC) transplantation to repair the injured spinal cord has shown consistent benefits in preclinical models. However, the low survival rate of grafted MSC is one of the most important problems. In the injured spinal cord, transplanted cells are exposed to hypoxic conditions and exposed to nutritional deficiency caused by poor vascular supply. Also, the transplanted MSCs face cytotoxic stressors that cause cell death. The aim of this study was to compare adipose-derived MSCs (AD-MSCs) and bone marrow-derived MSCs (BM-MSCs) isolated from individual C57BL6/J mice in relation to: (i) cellular characteristics, (ii) tolerance to hypoxia, oxidative stress and serum-free conditions, and (iii) cellular survival rates after transplantation. AD-MSCs and BM-MSCs exhibited a similar cell surface marker profile, but expressed different levels of growth factors and cytokines. To research their relative stress tolerance, both types of stromal cells were incubated at 20.5% O2 or 1.0% O2 for 7 days. Results showed that AD-MSCs were more proliferative with greater culture viability under these hypoxic conditions than BM-MSCs. The MSCs were also incubated under H2O2-induced oxidative stress and in serum-free culture medium to induce stress. AD-MSCs were better able to tolerate these stress conditions than BM-MSCs; similarly when transplanted into the spinal cord injury region in vivo, AD-MSCs demonstrated a higher survival rate post transplantation Furthermore, this increased AD-MSC survival post transplantation was associated with preservation of axons and enhanced vascularization, as delineated by increases in anti-gamma isotype of protein kinase C and CD31 immunoreactivity, compared with the BM-MSC transplanted group. Hence, our results indicate that AD-MSCs are an attractive alternative to BM-MSCs for the treatment of severe spinal cord injury. However, it should be noted that the motor function was equally improved following moderate spinal cord injury in both groups, but with no significant improvement seen unfortunately following severe spinal cord injury in either group.
Keywords: Adipose-derived mesenchymal stromal cell (AD-MSC); bone marrow-derived mesenchymal stromal cell (BM-MSC); spinal cord injury (SCI); treatment.
Conflict of interest statement
Figures






Similar articles
-
Role of bone marrow derived mesenchymal stromal cells and Schwann-like cells transplantation on spinal cord injury in adult male albino rats.Biomed Pharmacother. 2018 Dec;108:1365-1375. doi: 10.1016/j.biopha.2018.09.131. Epub 2018 Oct 5. Biomed Pharmacother. 2018. PMID: 30372839
-
Comparison of the Anti-Inflammatory Effects of Mouse Adipose- and Bone-Marrow-Derived Multilineage-Differentiating Stress-Enduring Cells in Acute-Phase Spinal Cord Injury.J Neurotrauma. 2023 Dec;40(23-24):2596-2609. doi: 10.1089/neu.2022.0470. Epub 2023 May 16. J Neurotrauma. 2023. PMID: 37051701
-
Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs.J Vet Med Sci. 2012 Dec;74(12):1617-30. doi: 10.1292/jvms.12-0065. Epub 2012 Aug 9. J Vet Med Sci. 2012. PMID: 22878503
-
A combination of mesenchymal stem cells and scaffolds promotes motor functional recovery in spinal cord injury: a systematic review and meta-analysis.J Neurosurg Spine. 2019 Nov 1;32(2):269-284. doi: 10.3171/2019.8.SPINE19201. Print 2020 Feb 1. J Neurosurg Spine. 2019. PMID: 31675724
-
Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1113-29. doi: 10.1007/s10571-006-9007-2. Epub 2006 Apr 22. Cell Mol Neurobiol. 2006. PMID: 16633897 Free PMC article. Review.
Cited by
-
Synergic Effect of Combined Therapy of Hyperbaric Oxygen and Adipose-Derived Mesenchymal Stem Cells on Improving Locomotor Recovery After Acute Traumatic Spinal Cord Injury in Rat Mainly Through Downregulating Inflammatory and Cell-Stress Signalings.Cell Transplant. 2022 Jan-Dec;31:9636897221133821. doi: 10.1177/09636897221133821. Cell Transplant. 2022. PMID: 36317711 Free PMC article.
-
Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy.Int J Mol Sci. 2019 May 31;20(11):2698. doi: 10.3390/ijms20112698. Int J Mol Sci. 2019. PMID: 31159345 Free PMC article. Review.
-
Adipose-Derived Mesenchymal Stromal Cell Transplantation for Severe Spinal Cord Injury: Functional Improvement Supported by Angiogenesis and Neuroprotection.Cells. 2023 May 25;12(11):1470. doi: 10.3390/cells12111470. Cells. 2023. PMID: 37296591 Free PMC article.
-
All the PNS is a Stage: Transplanted Bone Marrow Cells Play an Immunomodulatory Role in Peripheral Nerve Regeneration.ASN Neuro. 2023 Jan-Dec;15:17590914231167281. doi: 10.1177/17590914231167281. ASN Neuro. 2023. PMID: 37654230 Free PMC article.
-
Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis.Stem Cell Res Ther. 2020 Aug 31;11(1):374. doi: 10.1186/s13287-020-01889-z. Stem Cell Res Ther. 2020. PMID: 32867857 Free PMC article.
References
-
- Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 2007;40(7):609–619. - PubMed
-
- Lu Z, Xu S. ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life. 2006;58(11):621–631. - PubMed
-
- Watanabe S, Uchida K, Nakajima H, Matsuo H, Sugita D, Yoshida A, Honjoh K, Johnson WE, Baba H. Early transplantation of mesenchymal stem cells after spinal cord injury relieves pain hypersensitivity through suppression of pain-related signaling cascades and reduced inflammatory cell recruitment. Stem Cells. 2015;33(6):1902–1914. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical